2m 2m 2m 2m 2m 2m 2m
Biogen (BIIB)
NASDAQ
$252.20-$1.64 (-0.65%)
Price as of Oct 23, 2026 6:21 AM EDT- $37.5BMarket Cap
- 69.14%1-Year Change
- Drug Manufacturers - GeneralIndustry
Biogen (BIIB)
$252.20-$1.64 (-0.65%)
BIIB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $253.84 | ||
Change | +$12.86 (+5.34%) | ||
Open | $240.61 | ||
High | $254.41 | ||
Low | $240.02 | ||
Previous Close | $240.98 | ||
Volume | 2,237,506 | ||
30-Day Average Volume | 1,287,966 | ||
1-Week Change | 7.86% | ||
1-Month Change | 12.64% | ||
1-Year Change | 69.14% | ||
3-Year Change | -1.40% | ||
5-Year Change | -4.14% | ||
Fundamentals | |||
Shares Outstanding | 147.8M | ||
Total Assets | $32.1B | ||
Market Cap | $37.5B | ||
Enterprise Value | $44.3B | ||
Period: QTR TTM FY | |||
Revenue | $1.9B | ||
Net Income | $97.5M | ||
Free Cash Flow | $408.0M | ||
EBIT | $214.7M | ||
EBITDA | $450.8M | ||
Net Working Capital | $3.4B | ||
EPS | $0.66 | ||
Enterprise Value/EBITDA | 98 | ||
Enterprise Value/Revenue | 23 | ||
P/B | 2 | ||
P/E | 385 | ||
PEG | -6 | ||
Price/Free Cash Flow | 92 | ||
Price/Operating Cash Flow | 84 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue